Wells Fargo’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-128
| Closed | -$416 | – | 6501 |
|
|
2024
Q1 | $416 | Buy |
128
+2
| +2% | +$7 | ﹤0.01% | 5926 |
|
|
2023
Q4 | $2.58K | Buy |
126
+64
| +103% | +$1.31K | ﹤0.01% | 5615 |
|
|
2023
Q3 | $997 | Buy |
62
+27
| +77% | +$434 | ﹤0.01% | 5826 |
|
|
2023
Q2 | $298 | Sell |
35
-1,931
| -98% | -$16.4K | ﹤0.01% | 6274 |
|
|
2023
Q1 | $19.4K | Buy |
+1,966
| New | +$19.4K | ﹤0.01% | 5336 |
|
|
2022
Q4 | – | Sell |
-27
| Closed | – | – | 7112 |
|
|
2022
Q3 | $0 | Sell |
27
-46
| -63% | – | ﹤0.01% | 6281 |
|
|
2022
Q2 | $1K | Buy |
+73
| New | +$1K | ﹤0.01% | 6153 |
|